Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2022-06-28

Monkeypox: EMA starts review for Imvanex

View source ↗

Summary

EMA initiates a review of Imvanex in relation to Monkeypox to assess available evidence and potential regulatory actions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imvanex (Modified vaccinia Ankara (MVA-BN) vaccine)